Lnc RNA MALAT 1 is dysregulated in diabetic nephropathy and involved in high glucose‐induced podocyte injury via its interplay with β‐catenin
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Metastasis associated lung adenocarcinoma transcript 1(MALAT 1) is a long non‐coding RNA, broadly expressed in mammalian tissues including kidney and up‐regulated in a variety of cancer cells. To date, its functions in podocytes are largely unknown. β‐catenin is a key mediator in the canonical and non‐canonical Wnt signalling pathway; its aberrant expression promotes podocyte malfunction and albuminuria, and contributes to kidney fibrosis. In this study, we found that MALAT 1 levels were increased in kidney cortices from C57 BL/6 mice with streptozocin (STZ)‐induced diabetic nephropathy, and dynamically regulated in cultured mouse podocytes stimulated with high glucose, which showed a trend from rise to decline. The decline of MALAT 1 levels was accompanied with β‐catenin translocation to the nuclei and enhanced expression of serine/arginine splicing factor 1 (SRSF 1), a MALAT 1 RNA‐binding protein. Further we showed early interference with MALAT 1 si RNA partially restored podocytes function and prohibited β‐catenin nuclear accumulation and SRSF 1 overexpression. Intriguingly, we showed that β‐catenin was involved in MALAT 1 transcription by binding to the promotor region of MALAT 1; β‐catenin knock‐down also decreased MALAT 1 levels, suggesting a novel feedback regulation between MALAT 1 and β‐catenin. Notably, β‐catenin deletion had limited effects on SRSF 1 expression, demonstrating β‐catenin might serve as a downstream signal of SRSF 1. These findings provided evidence for a pivotal role of MALAT 1 in diabetic nephropathy and high glucose‐induced podocyte damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tripathi, V., Ellis, J. D., Shen, Z., Song, D. Y., Pan, Q., Watt, A. T., Freier, S. M., Bennett, C. F., Sharma, A., Bubulya, P. A., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.011 · Cited by 2,219 · cited 2×
“Depletion of MALAT1 or overexpression of an SR protein could change the alternative splicing of a similar set of endogenous pre-mRNAs [26].”
BackgroundThe many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598 · cited 1×
“The release of b-catenin, triggered by the loss of cadherin-mediated cell adhesion, has been extensively indicated in the literature to serve as a pivotal modulator engaged in EMT in numerous cancer cells [17, 55].”
BackgroundA Conditionally Immortalized Human Podocyte Cell Line Demonstrating Nephrin and Podocin Expression
Saleem, M. A., O’Hare, M. J., Reiser, J., Coward, R. J., Inward, C. D., Farren, T., Xing, C. Y., Ni, L., Mathieson, P. W., & Mundel, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v133630 · Cited by 1,120
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Molecular mechanisms of diabetic kidney disease
Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72271 · Cited by 909 · cited 1×
“Its excessive activation is also found in glomeruli of focal segmental glomerulosclerosis and diabetic nephropathy [15, 16].”
BackgroundSpector, D. L., & Lamond, A. I. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000646 · Cited by 819 · cited 2×
“Nuclear speckles were dynamic and irregularly shaped nuclear domains involved in pre-mRNA splicing processing and RNA transport in mammalian cells [20].”
BackgroundA long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression
Bernard, D., Prasanth, K. V., Tripathi, V., Colasse, S., Nakamura, T., Xuan, Z., Zhang, M. Q., Sedel, F., Jourdren, L., Coulpier, F., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.199 · Cited by 735 · cited 2×
“When RNA polymerase II-dependent transcription is active, MALAT1 becomes enriched in nuclear speckles-dynamic and irregularly shaped nuclear domains involved in pre-mRNA splicing processing and RNA transport in mammalian cells [20, 21].”
Background3′ End Processing of a Long Nuclear-Retained Noncoding RNA Yields a tRNA-like Cytoplasmic RNA
Wilusz, J. E., Freier, S. M., & Spector, D. L. (2008) · Cell · doi:10.1016/j.cell.2008.10.012 · Cited by 720
MALAT1 — a paradigm for long noncoding RNA function in cancer
Gutschner, T., Hämmerle, M., & Diederichs, S. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1028-y · Cited by 719 · cited 1×
“MALAT1 is a highly conserved mRNA-like long non-coding RNA (lncRNA), originally considered as a pivotal prognostic factor in various metastatic carcinomas [7, 8, 11].”
BackgroundPodocyte Biology and Response to Injury
Mundel, P., & Shankland, S. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000039661.06947.fd · Cited by 669 · cited 1×
“Podocytes are a key component of kidney filtration barrier [4, 5].”
BackgroundThe pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 625
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547 · cited 1×
“By shuttling between the nucleus and the cytoplasm, SRSF1 interacted with and activated mTOR to promote translation [22, 23, 48]; dysregulation of the latter was sufficient to facilitate glomerular diseases [49].”
BackgroundActin up: regulation of podocyte structure and function by components of the actin cytoskeleton
Faul, C., Asanuma, K., Yanagida-Asanuma, E., Kim, K., & Mundel, P. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.06.006 · Cited by 524 · cited 1×
“Podocytes are a key component of kidney filtration barrier [4, 5].”
BackgroundBoon, R. A., Jaé, N., Holdt, L., & Dimmeler, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.051 · Cited by 516 · cited 1×
“Long noncoding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides and have emerged as important regulators in a variety of cellular responses, developmental and disease processes [1].”
BackgroundEngreitz, J. M., Sirokman, K., McDonel, P., Shishkin, A. A., Surka, C., Russell, P., Grossman, S. R., Chow, A. Y., Guttman, M., & Lander, E. S. (2014) · Cell · doi:10.1016/j.cell.2014.08.018 · Cited by 500
β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis
Monga, S. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.056 · Cited by 487 · cited 1×
“b-catenin is a key intracellular signal transducer in the Wnt signalling pathway [13], which is *Correspondence to: Zhimei LV E-mail: zhimeilv@sina.”
BackgroundTargeting long non-coding RNAs in cancers: Progress and prospects
Li, C. H., & Chen, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.030 · Cited by 473 · cited 1×
“Prior studies showed MALAT1 acted as an important oncogene in numerous cancers [10, 11].”
BackgroundThe Glomerular Slit Diaphragm Is a Modified Adherens Junction
REISER, J., KRIZ, W., KRETZLER, M., & MUNDEL, P. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1111 · Cited by 466
Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2207 · Cited by 447 · cited 1×
“By shuttling between the nucleus and the cytoplasm, SRSF1 interacted with and activated mTOR to promote translation [22, 23, 48]; dysregulation of the latter was sufficient to facilitate glomerular diseases [49].”
BackgroundDevelopmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog
Edeling, M., Ragi, G., Huang, S., Pavenstädt, H., & Susztak, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.54 · Cited by 430 · cited 1×
“hyperactivated in response to injury and contributes to kidney fibrosis [14].”
BackgroundPathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
Liu, J.-Y., Yao, J., Li, X.-M., Song, Y.-C., Wang, X.-Q., Li, Y.-J., Yan, B., & Jiang, Q. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.466 · Cited by 427 · cited 2×
“Previous studies demonstrated MALAT1 was significantly increased in high glucose-treated retinal endothelial cells and in the retinas of diabetic mice [9], implying a role of MALAT1 in diabetes microvascular complication.”
BackgroundResultSelf-citationCáceres, J. F., Misteli, T., Screaton, G. R., Spector, D. L., & Krainer, A. R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.2.225 · Cited by 416 · cited 1×
“SRSF1 is the archetype member of the SR protein family, involved in key steps of mRNA metabolism, such as nuclear export of the mature mRNA [22, 45].”
BackgroundWnt/β-Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria
Dai, C., Stolz, D. B., Kiss, L. P., Monga, S. P., Holzman, L. B., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010019 · Cited by 399 · cited 1×
“Its excessive activation is also found in glomeruli of focal segmental glomerulosclerosis and diabetic nephropathy [15, 16].”
BackgroundLi, Y., Kang, Y. S., Dai, C., Kiss, L. P., Wen, X., & Liu, Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070057 · Cited by 338 · cited 1×
“and our previous studies illustrated that EMT was a potential mechanism leading to podocyte malfunction [18, 53].”
Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
Das, S., & Krainer, A. R. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0131 · Cited by 298 · cited 3×
“By shuttling between the nucleus and the cytoplasm, SRSF1 interacted with and activated mTOR to promote translation [22, 23, 48]; dysregulation of the latter was sufficient to facilitate glomerular diseases [49].”
BackgroundÄnkö, M.-L., Müller-McNicoll, M., Brandl, H., Curk, T., Gorup, C., Henry, I., Ule, J., & Neugebauer, K. M. (2012) · Genome Biology · doi:10.1186/gb-2012-13-3-r17 · Cited by 277 · cited 1×
“indirectly through protein intermediates [43, 44].”
The podocyte slit diaphragm--from a thin grey line to a complex signalling hub
Grahammer, F., Schell, C., & Huber, T. B. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.169 · Cited by 269 · cited 2×
“The intense expression of ZO-1 is a prerequisite for the formation of SD and allows the proper binding of SD proteins to actin cytoskeleton [39, 40].”
BackgroundWT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Amin, E. M., Oltean, S., Hua, J., Gammons, M. V. R., Hamdollah-Zadeh, M., Welsh, G. I., Cheung, M.-K., Ni, L., Kase, S., Rennel, E. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.016 · Cited by 253 · cited 2×
“In WT-1 mutant podocytes, SRSF1 promoted the expression of pro-angiogenic VEGF-a splice isoforms and caused imbalanced angiogenesis [27].”
BackgroundLong non-coding RNAs in cancer progression
Tano, K., & Akimitsu, N. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00219 · Cited by 251 · cited 2×
“Prior studies showed MALAT1 acted as an important oncogene in numerous cancers [10, 11].”
BackgroundGenomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
Jiang, L., Huang, J., Higgs, B. W., Hu, Z., Xiao, Z., Yao, X., Conley, S., Zhong, H., Liu, Z., Brohawn, P., et al. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005895 · Cited by 241 · cited 1×
“In small cell lung cancer, SRSF1 silencing suppressed PI3K/AKT and MEK/ERK pathways, activation of the latter was associated with PKB-mediated phosphorylation of GSK-3b thereby released and stabilized cytoplasmic b-catenin [50, 51].”
BackgroundZhou, X., Liu, S., Cai, G., Kong, L., Zhang, T., Ren, Y., Wu, Y., Mei, M., Zhang, L., & Wang, X. (2015) · Scientific Reports · doi:10.1038/srep15972 · Cited by 228 · cited 3×
“Growing evidence has illustrated that MALAT1 played a negligible role in epithelial-mesenchymal transition (EMT) of diverse cancer cells [12].”
BackgroundInfluentialCheng, S., Pollock, A. S., Mahimkar, R., Olson, J. L., Lovett, D. H., Cheng, S., Pollock, A. S., Mahimkar, R., Olson, J. L., & Lovert, D. H. (2006) · The FASEB Journal · doi:10.1096/fj.06-5898fje · Cited by 223 · cited 2×
“Next, we analysed the effects of high glucose on the expression of matrix metalloproteinases (MMPs), which were responsible for the turnover and breakdown of extra-cellular matrix (ECM) and glomerulus [34], and we found a hyperactivity of MMP-2 was driven by highglucose treatment (P < 0.”
BackgroundMALAT1 long non-coding RNA in cancer
Yoshimoto, R., Mayeda, A., Yoshida, M., & Nakagawa, S. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.09.012 · Cited by 222 · cited 1×
“MALAT1 is a highly conserved mRNA-like long non-coding RNA (lncRNA), originally considered as a pivotal prognostic factor in various metastatic carcinomas [7, 8, 11].”
BackgroundMALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF
Wang, J., Su, L., Chen, X., Li, P., Cai, Q., Yu, B., Liu, B., Wu, W., & Zhu, Z. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.04.007 · Cited by 164 · cited 1×
“It was found that MALAT1 promoted cell proliferation in gastric cancer by recruiting SRSF1 and modulated SRSF1 distribution to nuclear speckles in Hela cells [25, 26].”
BackgroundThe role of the podocyte in glomerulosclerosis
Kriz, W., & Lemley, K. V. (1999) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-199907000-00014 · Cited by 160
Kumar, P. A., Welsh, G. I., Saleem, M. A., & Menon, R. K. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00151 · Cited by 160 · cited 1×
“property as a size and shape selective glomerular barrier [31, 38].”
BackgroundZhou, Q., Chung, A. C. K., Huang, X. R., Dong, Y., Yu, X., & Lan, H. Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.10.007 · Cited by 148 · cited 1×
“Evidence has shown that lncRNAs are associated with TGF-b/Smad3-mediated renal inflammation and fibrosis [2] and might be functionally important in modulating renal responses to hyperglycaemia and the progression of diabetic nephropathy, a major microvascular complication of diabetes and one of the leading causes of e…”
BackgroundA new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review)
Fan, Y., Zheng, M. H., TANG, Y.-L., & Liang, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1555 · Cited by 146 · cited 2×
“EMT is a reversible dedifferentiation process that converts epithelial cancer cells into dedifferentiated cells, characterized by the loss of epithelial traits such as E-cadherin and the acquisition of fibroblastic markers a-smooth muscle actin (a-SMA) and fibroblast-specific protein-1 (FSP-1) [18, 54].”
BackgroundUpregulation of nestin, vimentin, and desmin in rat podocytes in response to injury
Zou, J., Yaoita, E., Watanabe, Y., Yoshida, Y., Nameta, M., Li, H., Qu, Z., & Yamamoto, T. (2006) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0134-9 · Cited by 141 · cited 1×
“Desmin was one of the intermediate filament proteins and has been widely recognized as an important indicator for podocyte injury [33].”
BackgroundFu, Y., Huang, B., Shi, Z., Han, J., Wang, Y., Huangfu, J., & Wu, W. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202218 · Cited by 130 · cited 2×
“Recent studies suggested that human SRSF1 and SRSF9 were able to enhance Wnt1 as well as b-catenin-induced reporter expression, whereas SRSF2 could not [24].”
BackgroundSRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles
Tripathi, V., Song, D. Y., Zong, X., Shevtsov, S. P., Hearn, S., Fu, X.-D., Dundr, M., & Prasanth, K. V. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-03-0206 · Cited by 128 · cited 3×
“By shuttling between the nucleus and the cytoplasm, SRSF1 interacted with and activated mTOR to promote translation [22, 23, 48]; dysregulation of the latter was sufficient to facilitate glomerular diseases [49].”
BackgroundWang, J., Wang, H., Zhang, Y., Zhen, N., Zhang, L., Qiao, Y., Weng, W., Liu, X., Ma, L., Xiao, W., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.022 · Cited by 118 · cited 1×
“As SRSF1 was engaged in the nonsense-mediated mRNA decay (NMD) mRNA quality surveillance, besides its splicing capability [23, 46], we speculated early imbalance of MALAT1 might have also triggered a degradation mechanism, which, with SRSF1 potentially involved, resulted in an overcorrection of MALAT1 levels and podoc…”
BackgroundAlvarez, M. L., & DiStefano, J. K. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.010 · Cited by 116
Whiteside, C. I., Cameron, R., Munk, S., & Levy, J. (1993) · PubMed Central · Cited by 107
Takano, Y., Yamauchi, K., Hayakawa, K., Hiramatsu, N., Kasai, A., Okamura, M., Yokouchi, M., Shitamura, A., Yao, J. Q., & Kitamura, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2006.12.051 · Cited by 96 · cited 1×
“In podocytes, activated PI3K/AKT pathway was involved in transcriptional suppression of nephrin, a key SD protein that anchored the SD to the actin cytoskeleton [39, 52].”
BackgroundNatural antisense RNA promotes 3′ end processing and maturation of MALAT1 lncRNA
Zong, X., Nakagawa, S., Freier, S. M., Fei, J., Ha, T., Prasanth, S. G., & Prasanth, K. V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw047 · Cited by 94 · cited 1×
“Mature MALAT1 is localized in the cell nuclei with a cytoplasmic tRNA-like small RNA, known as mascRNA [19].”
BackgroundFunctional consequences of integrin-linked kinase activation in podocyte damage
Teixeira, V. P. C., Blattner, S. M., Li, M., Anders, H., Cohen, C. D., Edenhofer, I., Calvaresi, N., Merkle, M., Rastaldi, M. P., & Kretzler, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67108.x · Cited by 91 · cited 2×
“Pcadherin suppression by ILK activation is linked to podocyte detachment from the glomerular basement membrane (GBM) [35].”
BackgroundLv, Z., Hu, M., Zhen, J., Lin, J., Wang, Q., & Wang, R. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.11.003 · Cited by 80 · cited 8×
“Cell differentiation was induced by maintaining podocytes on type I collagen at 37°C without cinterferon under non-permissive conditions for at least 14 days [18, 29].”
BackgroundMethodInfluentialSelf-citationDoes GSK-3 provide a shortcut for PI3K activation of Wnt signalling?
Voskas, D., Ling, L. S., & Woodgett, J. R. (2010) · F1000 Biology Reports · doi:10.3410/b2-82 · Cited by 68
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases
Oltean, S., Gammons, M. V. R., Hulse, R. P., Hamdollah‐Zadeh, M., Mavrou, A., Donaldson, L. F., Salmon, A. H. J., Harper, S. J., Ladomery, M., & Bates, D. O. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120051 · Cited by 67 · cited 1×
“Prior studies suggested that lncRNA MALAT1 was raised in the retinas of STZ-induced diabetic rats, blockade of which alleviated retinal inflammation via reducing expression of ICAM, VEGF and TNF-a [9]; misregulation of VEGF was often observed in clinical or experimental diabetic nephropathy, involved in matrix accumul…”
BackgroundHolthöfer, H. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm344 · Cited by 44
Focusing on the Glomerular Slit Diaphragm
Miner, J. H. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64341-6 · Cited by 37 · cited 1×
“property as a size and shape selective glomerular barrier [31, 38].”
BackgroundBeta-Catenin Versus the Other Armadillo Catenins
Miller, R. K., Hong, J. Y., Muñoz, W. A., & McCrea, P. D. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394311-8.00017-0 · Cited by 35
CD154 Induces Matrix Metalloproteinase‐9 Secretion in Human Podocytes
Rigothier, C., Daculsi, R., Lepreux, S., Auguste, P., Villeneuve, J., Dewitte, A., Doudnikoff, É., Saleem, M. A., Bourget, C., Combe, C., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25571 · Cited by 25 · cited 1×
“Matrix metalloproteinase-2 (MMP-2) contributes to GBM turnover via its ability to breakdown of extra-cellular matrix (ECM) and glomerulus [41]; overexpression of MMP-2 in transgenic mice promotes renal fibrosis and generates broad spectrum of pathological and functional characteristics of human CKD [34].”
BackgroundEffects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human Podocytes
Park, S. J., Saleem, M. A., Nam, J.-A., Ha, T., & Shin, J. I. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.2.426 · Cited by 20 · cited 1×
“The intense expression of ZO-1 is a prerequisite for the formation of SD and allows the proper binding of SD proteins to actin cytoskeleton [39, 40].”
Background
Cited by
Jing, F., Zhao, J., Jing, X., & Lei, G. (2020) · Cell Biology International · doi:10.1002/cbin.11392 · Cited by 28
Metadata
- Authors
- Hu, M., Wang, R., Li, X., Fan, M., Lin, J., Zhen, J., Chen, L., & Lv, Z.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2017-04-26
- Volume
- 21
- Issue
- 11
- Pages
- 2732-2747
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2607646028
- Cited by
- 189
- References
- 55
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.